Skip to main content

Part of the book series: Essentials in Ophthalmology ((ESSENTIALS))

  • 1094 Accesses

Abstract

Langerhans cell histiocytosis is a rare disease consistent in its histologic characteristics, but variable in both phenotypic presentation and prognosis. Classically, a soft tissue mass with adjacent bony destruction is often present that shows a histologic monoclonal proliferation of cells positive for CD1a, S100, and langerin (CD207). Pathognomonic Birbeck granules may be seen on transmission electron microscopy. In this review, the diagnosis, etiologies, treatments, and, most importantly, the classification schemes are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 59.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 79.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Herwig MC, Wojno T, Zhang Q, Grossniklaus HE. Langerhans cell histiocytosis of the orbit: five clinicopathologic cases and review of the literature. Surv Ophthalmol. 2013;58:330–40.

    Article  PubMed Central  PubMed  Google Scholar 

  2. Giovannetti F, Giona F, Ungari C, et al. Langerhans cell histiocytosis with orbital involvement: our experience. J Oral Maxillofac Surg. 2009;67:212–6.

    Article  PubMed  Google Scholar 

  3. Margo CE, Goldman DR. Langerhans cell histiocytosis. Surv Ophthalmol. 2008;53:332–58.

    Article  PubMed  Google Scholar 

  4. Harris GJ. Langerhans cell histiocytosis of the orbit: a need for interdisciplinary dialogue. Am J Ophthalmol. 2006;141:374–8.

    Article  PubMed  Google Scholar 

  5. Harris GJ, Woo KI. Is unifocal Langerhans-cell histiocytosis of the orbit a “CNS-Risk” lesion? Pediatr Blood Cancer. 2004;43(3):298–9, author reply 300–1.

    Article  PubMed  Google Scholar 

  6. Stalemark H, Laurencikas E, Karis J, et al. Incidence of Langerhans cell histiocytosis in children: a population-based study. Pediatr Blood Cancer. 2008;51(1):76–81.

    Article  PubMed  Google Scholar 

  7. Maccheron LJ, McNab AA, Elder J, et al. Ocular adnexal Langerhans cell histiocytosis clinical features and management. Orbit. 2006;25(3):169–77.

    Article  PubMed  Google Scholar 

  8. Cheung N, Selva D, McNab AA. Orbital Langerhans cell histiocytosis in adults. Ophthalmology. 2007;114:1569–73.

    Article  PubMed  Google Scholar 

  9. Cochrane LA, Prince M, Clarke K. Langerhans’ cell histiocytosis in the paediatric population: presentation and treatment of head and neck manifestations. J Otolaryngol. 2003;32(1):33–7.

    Article  PubMed  Google Scholar 

  10. Morimoto A, Oh Y, Shioda Y, et al. Recent advances in Langerhans cell histiocytosis. Pediatr Int. 2014;56:451–61.

    Article  CAS  PubMed  Google Scholar 

  11. Broadbent V, Gadner H. Current therapy for Langerhans cell histiocytosis. Hematol Oncol Clin North Am. 1998;12(2):327–38.

    Article  CAS  PubMed  Google Scholar 

  12. Grois N, Flucher-Wolfram B, Heitger A, et al. Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study. Med Pediatr Oncol. 1995;24(4):248–56.

    Article  CAS  PubMed  Google Scholar 

  13. Haupt R, Nanduri V, Calevo MG, et al. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Pediatr Blood Cancer. 2004;42(5):438–44.

    Article  PubMed  Google Scholar 

  14. Grois N, Potschger U, Prosch H, et al. Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatr Blood Cancer. 2006;46(2):228–33.

    Article  CAS  PubMed  Google Scholar 

  15. Grois N, Prayer D, Prosch H, et al. Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis. Pediatr Blood Cancer. 2004;43(1):59–65.

    Article  PubMed  Google Scholar 

  16. Minov M, Grois N, McClain K, et al. Histiocyte society evaluation and treatment guidelines. http://www.histiocytesociety.org/document.doc?id=290. Apr 2009.

Download references

Compliance with Ethical Standards

Zachary D. Pearce, Adam S. Hassan, and Hakan Demirci declare that they have no conflict of interest. No human studies were carried out by the authors for this article. No animal studies were carried out by the authors for this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zachary D. Pearce DO .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Pearce, Z.D., Demirci, H., Hassan, A.S. (2015). Langerhans Cell Histiocytosis. In: Demirci, H. (eds) Orbital Inflammatory Diseases and Their Differential Diagnosis. Essentials in Ophthalmology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-46528-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-46528-8_8

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-46527-1

  • Online ISBN: 978-3-662-46528-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics